glp-1 with medicaid Medicare, will cover weight-loss drugs next year Medicare cuts cost of popular

References Drucker DJ

To the wellness industry, GLP-1s actual significance doesnt seem to matter nearly as much as its association with thinness

Which is safer

There are currently five medications on the FDA-approved list for long-term use for weight loss: Wegovy (semaglutide) Saxenda (liraglutide) Xenical and Alli (orlistat) Qsymia (phentermine-topiramate) Contrave (bupropion/naltrexone) The above list does not include medications indicated for short-term use such as phentermine or medications prescribed off-label like Ozempic or Mounjaro

Both oral and injectable GLP-1 treatments may cause nausea, vomiting, constipation, diarrhea, abdominal discomfort, and reduced food tolerance

Srenson's thinking was coloured by the fact that a previous drug, Redux, approved in 1996 by the FDA for weight loss and launched with great fanfare, had to be withdrawn a year later after it was found to cause major heart attacks and to be largely ineffective